ANVS vs CRL · $80.4M cap vs rev $2.00B
Annovis Bio Inc (ANVS) versus Charles River Laboratories (CRL) — a side-by-side from cached financials, not a winner call.
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Latest reported ANVS revenue for 2026-06-30 was $0. Net income was -$32.4M. ANVS currently screens at market cap $80.4M.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
ANVS currently screens at market cap $80.4M. CRL currently screens at market cap $7.78B.
Not investment advice. Open the ANVS and CRL stock pages for the full models.
Not investment advice.